UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A measurement of the energy spectra and relative abundance of the cosmic-ray H and He isotopes over a broad energy range

The Astrophysical journal, 1983-12, Vol.275 (1), p.391-404

1983

Volltextzugriff (PDF)

Fluctuations in the Energy Loss of 66- and 100-MeV Protons in a Thin Proportional Counter

Physical review. A, General physics, 1972, Vol.6 (1), p.250-255

1972

Volltextzugriff (PDF)

A pulsed spark-discharge counter module

Nuclear instruments & methods, 1974-01, Vol.122, p.491-498

1974

Volltextzugriff (PDF)

Exploring the melanoma survivorship experience: a qualitative study

British journal of dermatology (1951), 2021-07, Vol.185 (1), p.221-223

2021

Volltextzugriff (PDF)

Effect of immunotherapy time-of-day infusion on overall survival among patients with advanced melanoma in the USA (MEMOIR): a propensity score-matched analysis of a single-centre, longitudinal study

The lancet oncology, 2021-12, Vol.22 (12), p.1777-1786

2021

Volltextzugriff (PDF)

Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma

The New England journal of medicine, 2021-09, Vol.385 (13), p.1196-1206

2021

Volltextzugriff (PDF)

Patient preferences regarding incidental genomic findings discovered during tumor profiling

Cancer, 2016-05, Vol.122 (10), p.1588-1597

2016

Volltextzugriff (PDF)

Institutional Outcomes of Whole Brain Radiotherapy for Metastatic Melanoma Brain Metastases

International journal of radiation oncology, biology, physics, 2020-11, Vol.108 (3), p.e687-e687

2020

Volltextzugriff (PDF)

Predictors of Overall and Progression-Free Survival in Patients with Ocular Melanoma Metastatic to the Liver Undergoing Y90 Radioembolization

Cardiovascular and interventional radiology, 2020-02, Vol.43 (2), p.254-263

2020

Volltextzugriff (PDF)

Tregs protect against combination checkpoint blockade toxicity induced by TPH and B cell interactions

The Journal of clinical investigation, 2024-06, Vol.134 (12), p.1-2

2024

Volltextzugriff (PDF)

Characterization and cloning of T24, a Taenia solium antigen diagnostic for cysticercosis

Molecular and biochemical parasitology, 2006-05, Vol.147 (1), p.109-117

2006

Volltextzugriff (PDF)

Institutional outcomes of whole brain radiotherapy for metastatic melanoma brain metastases

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e14504-e14504

2020

Volltextzugriff (PDF)

Case Report: Delayed Onset Multi-Organ Toxicities in a Melanoma Patient Achieving Complete Response to BRAF/MEK Inhibition

Frontiers in oncology, 2022-03, Vol.12, p.836845

2022

Volltextzugriff (PDF)

Clinical trials in melanoma patients with brain metastases

Pigment cell and melanoma research, 2015-11, Vol.28 (6), p.741-743

2015

Volltextzugriff (PDF)

821P Safety and efficacy of infrequent tebentafusp treatment omissions in patients with metastatic uveal melanoma

Annals of oncology, 2022-09, Vol.33, p.S923

2022

Volltextzugriff (PDF)

1097P Long-term follow-up of advanced melanoma (unresectable/metastatic - aMel) patients (pts) treated with fianlimab (FIAN) + cemiplimab (CEMI): Results from blinded independent central review (BICR) efficacy assessment

Annals of oncology, 2024-09, Vol.35, p.S726-S727

2024

Volltextzugriff (PDF)

The importance of surgery in scalp angiosarcomas

Surgical oncology, 2018-12, Vol.27 (4), p.A3-A8

2018

Volltextzugriff (PDF)

792MO Neoadjuvant pepinemab in combination with nivolumab and/or ipilimumab in resectable stage III melanoma

Annals of oncology, 2022-09, Vol.33, p.S906

2022

Volltextzugriff (PDF)

Clinical Correlation between Acute Exudative Polymorphous Paraneoplastic Vitelliform Maculopathy and Metastatic Melanoma Disease Activity: A 48-month Longitudinal Case Report

Ocular immunology and inflammation, 2022-02, Vol.30 (2), p.330-337

2022

Volltextzugriff (PDF)

Winship 4851-19: A pilot study of neoadjuvant and adjuvant cemiplimab for high-risk cutaneous squamous cell carcinoma

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.TPS9593-TPS9593

2021

Volltextzugriff (PDF)

Phase 1, 2 trial of concurrent anti-PD1 and stereotactic radiosurgery for melanoma and non-small cell lung cancer brain metastases (NCT02858869)

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.2022-2022

2021

Volltextzugriff (PDF)

A phase 1 study of fianlimab (anti-LAG-3) in combination with cemiplimab (anti-PD-1) in patients with advanced melanoma: Poor-prognosis subgroup analysis

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.9548-9548

2023

Volltextzugriff (PDF)

Significant durable response with fianlimab (anti-LAG-3) and cemiplimab (anti-PD-1) in advanced melanoma: Post adjuvant PD-1 analysis

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.9501-9501

2023

Volltextzugriff (PDF)

Interim results of prospective pilot phase II trial of concurrent anti-PD-1 and stereotactic radiosurgery (SRS) for melanoma and NSCLC patients with brain metastases (NCT02858869)

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e22002-e22002

2020

Volltextzugriff (PDF)

Characterization of the 8-Kilodalton Antigens of Taenia solium Metacestodes and Evaluation of Their Use in an Enzyme-Linked Immunosorbent Assay for Serodiagnosis

Journal of Clinical Microbiology, 2003-06, Vol.41 (6), p.2577-2586

2003

Volltextzugriff (PDF)

1 – 25 von 88

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(79)
Mit Volltextzugriff
(76)

Publikationsform

Sprache

Englisch
(88)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

A measurement of the energy spectra and relative abundance of the cosmic-ray H and He isotopes over a broad energy range

Fluctuations in the Energy Loss of 66- and 100-MeV Protons in a Thin Proportional Counter

A pulsed spark-discharge counter module

Exploring the melanoma survivorship experience: a qualitative study

Effect of immunotherapy time-of-day infusion on overall survival among patients with advanced melanoma in the USA (MEMOIR): a propensity score-matched analysis of a single-centre, longitudinal study

Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma

Patient preferences regarding incidental genomic findings discovered during tumor profiling

Institutional Outcomes of Whole Brain Radiotherapy for Metastatic Melanoma Brain Metastases

Predictors of Overall and Progression-Free Survival in Patients with Ocular Melanoma Metastatic to the Liver Undergoing Y90 Radioembolization

Tregs protect against combination checkpoint blockade toxicity induced by TPH and B cell interactions

Characterization and cloning of T24, a Taenia solium antigen diagnostic for cysticercosis

Institutional outcomes of whole brain radiotherapy for metastatic melanoma brain metastases

Case Report: Delayed Onset Multi-Organ Toxicities in a Melanoma Patient Achieving Complete Response to BRAF/MEK Inhibition

Clinical trials in melanoma patients with brain metastases

821P Safety and efficacy of infrequent tebentafusp treatment omissions in patients with metastatic uveal melanoma

1097P Long-term follow-up of advanced melanoma (unresectable/metastatic - aMel) patients (pts) treated with fianlimab (FIAN) + cemiplimab (CEMI): Results from blinded independent central review (BICR) efficacy assessment

The importance of surgery in scalp angiosarcomas

792MO Neoadjuvant pepinemab in combination with nivolumab and/or ipilimumab in resectable stage III melanoma

Clinical Correlation between Acute Exudative Polymorphous Paraneoplastic Vitelliform Maculopathy and Metastatic Melanoma Disease Activity: A 48-month Longitudinal Case Report

Winship 4851-19: A pilot study of neoadjuvant and adjuvant cemiplimab for high-risk cutaneous squamous cell carcinoma

Phase 1, 2 trial of concurrent anti-PD1 and stereotactic radiosurgery for melanoma and non-small cell lung cancer brain metastases (NCT02858869)

A phase 1 study of fianlimab (anti-LAG-3) in combination with cemiplimab (anti-PD-1) in patients with advanced melanoma: Poor-prognosis subgroup analysis

Significant durable response with fianlimab (anti-LAG-3) and cemiplimab (anti-PD-1) in advanced melanoma: Post adjuvant PD-1 analysis

Interim results of prospective pilot phase II trial of concurrent anti-PD-1 and stereotactic radiosurgery (SRS) for melanoma and NSCLC patients with brain metastases (NCT02858869)

Characterization of the 8-Kilodalton Antigens of Taenia solium Metacestodes and Evaluation of Their Use in an Enzyme-Linked Immunosorbent Assay for Serodiagnosis

Suchergebnisse filtern